| Literature DB >> 32344540 |
Sotirios Kiokias1, Charalampos Proestos2, Vassiliki Oreopoulou3.
Abstract
Nature has generously offered a wide range of herbs (e.g., thyme, oregano, rosemary, sage, mint, basil) rich in many polyphenols and other phenolic compounds with strong antioxidant and biochemical properties. This paper focuses on several natural occurring phenolic acids (caffeic, carnosic, ferulic, gallic, p-coumaric, rosmarinic, vanillic) and first gives an overview of their most common natural plant sources. A summary of the recently reported antioxidant activities of the phenolic acids in o/w emulsions is also provided as an in vitro lipid-based model system. Exploring the interfacial activity of phenolic acids could help to further elucidate their potential health properties against oxidative stress conditions of biological membranes (such as lipoproteins). Finally, this review reports on the latest literature evidence concerning specific biochemical properties of the examined phenolic acids.Entities:
Keywords: antioxidants; emulsions; health properties; phenolic acids
Year: 2020 PMID: 32344540 PMCID: PMC7231038 DOI: 10.3390/foods9040534
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Natural sources of the examined phenolic acids along with the most recent literature references.
| Phenolic Acid Structure | Natural Source | Amount(g/kg, Dry Basis) | Literature |
|---|---|---|---|
|
| Coffee | 0.90 a | [ |
| Blueberry | 1.47 a | [ | |
| Yerba mate | 1.50 | [ | |
| Banana | 0.23–0.31 | [ | |
| Mango | 1.00–1.76 | [ | |
|
| 0.2–2.9 | [ | |
|
| Black tea | 0.8 | [ |
| banana | 1.10–1.24 | [ | |
| mango | 11.45–34.49 | [ | |
| berries | 0.03–0.09 a | [ | |
| chestnut | 3.50–9.10 a | [ | |
|
|
| 0.16–12.86 | [ |
|
| 1.18 a–21.86 | [ | |
| oregano species | 0.05–25.63 | [ | |
| thyme | 0.08–6.81 | [ | |
| Sweet basil | 10.86 | [ | |
| Pink savory ( | 19.50 | [ | |
|
| Rosemary leaves | 40–100 | [ |
| ( | |||
| salvia species | 0.1–21.8 | [ | |
| Sage ( | 15–25 | [ | |
|
| Cereal grains | Up to 2 | [ |
| Cell walls of grains | 13.51–33.00 | [ | |
| Flaxseed | 4.10 (as glucoside) | [ | |
| artichoke | 2.75 | [ | |
| coffee | 0.09–0.14 | [ | |
| eggplant, redbeet, spinach, peanut | 0.07–0.35 | [ | |
| grapefruit, and orange | |||
| Banana | 0.49–0.53 | [ | |
| Mango | 0.75 | [ | |
| Beans | 0.8 | [ | |
| Acai ( | 0.10 | [ | |
|
| Strawberries | 1.11 | [ |
| Berries | 0.01–0.95 | [ | |
| Pear | 0.01–0.45 | [ | |
| Banana | 1.05 | [ | |
| Mango | 0.90 | [ | |
| Peanuts | 1.03 a | [ | |
| Onion peel | 0.58 | [ | |
| Honey | 0.002–0.005 | [ | |
| Mushrooms | Traces–3.70 | [ | |
|
| 0.028–0.042 | [ | |
|
| Banana | 0.12–0.37 | [ |
| Mango | 0.47–3.76 | [ | |
| Acai ( | 0.002 | [ | |
|
| 1.1–1.3 | [ | |
| Potato tuber ( | 0.02-0.04 | [ |
a: on fresh weight basis.
Overview of recent in vitro and in vivo clinical studies on the beautiful health/biochemical properties of the examined phenolic acids.
| Phenolic Acid. | Experimental Conditions | Conclusion of Study/Health Effect | Reference |
|---|---|---|---|
|
| Treatment of rats with CA (20 mg/kg body wt). | CA caused suppression of tumor growth in HCC cells (HepG2)/reduction of tumor invasion at liver metastasis. | [ |
| CAPE and its analogs (20 mg/kg body wt) in rats. | CA chemoprotective effect on cell proliferation, p56 activation of hepatic tumors (HCC). | [ | |
| CA (100 mg/kg) in the rat microbiota | CA reduce certain biomarkers that indicate liver injury | [ | |
| Treatment of human breast cancer cells with 20 μg/mL CarA | CarA activated the expression of antioxidant/apoptosis genes resulting in protection against breast cancer. | [ | |
| P450 enzyme inhibition was examined in human hepatocytes and microsomes at presence of 4-10 μM of CarA | Increased enzyme activity at 10 mM of CarA, compared to drugs/need for CarA safety assessment before its use against hepatotoxicity | [ | |
|
| Treatment of T98G human cells for 24 h with GA (in the range 1-100 μg/mL). | GA exerts a protective anti-proliferative effect on glioma T98G cells via dose-dependent epigenetic regulation mediated by miRNAs. | [ |
| Oral administration of GA monohydrate (50 and 100 mg/kg body wt) in normal myocardial infracted rats. | Cardioprotective effect of GA. | [ | |
|
| Treatment of Dawley rats with FA (100 mg/kg body wt). | FA exerted a neuroprotective role by attenuating decreases of peroxiredoxin-2 and thioredoxin levels in neuronal cell injury. | [ |
| Treatment in the skin of salbino mice exposed to UVB (180 mJ/cm2) for 30 weeks. | FA protected against carcinogenesis and tumor formation. | [ | |
|
| Treatment of Caco-2 cells with 150 μM p-CA for 24 h, | p-CA protective effect against the development of colon cancer retarding the cell cycle progression | [ |
| Treatment of rats (50-200 mg/kg body wt) challenged with colon specific procarcinogen DMH. | p-CA exhibits a significant chemo-preventive potential at 100 mg/kg | [ | |
| Treatment of cultures of mice cortical neuron with p-CA (1 mM) against cysteinyldopamine-induced neurotoxicity. | p-CA provided the best neuroprotection, compared to other phenolics (CA and GA). | [ | |
|
| Study of RA effect (0.01 mg/mL) on cell viability and normal cellular function in human neuronal cells | RA at 0.01 mg/mL (but not higher) exerted a neuroprotective effect generating significant decrease in CTX-mediated extracellular LDH activity compared to control. | [ |
| Treatment of mice (100 mg/kg body wt) and study of the effect on ethanol-induced DNA damage. | Anti-genotoxic capacity of RA against DNA damage (via comet assay) | [ | |
| Supplementation of rats with RA (5–20 mg/kg body wt). | RA protected treated rats from the deleterious effects caused by colon carcinogen, 1,2-dimethylhydrazine. | [ | |
|
| Supplementation of male rats (0–10 mg/kg body wt) for 10 days. | VA was effective against the risk of myocardial dysfunction. | [ |
| In vitro examination of the effect on mitomycin C-induced genomic damage in human lymphocytes. | VA (at 1 µg/mL) significantly reduced DNA damage cells but at a higher (2 µg/mL) itself exerted genotoxic effects on DNA. | [ | |
| Supplementation of 5 groups of mice with VA (5–100 mg/kg body wt) for 28 days | VA at 50 and 100 mg/kg dose significantly ( | [ |